Post date March 22, 2024 Experience Auna $360 million U.S. IPO We advised Auna on its U.S. IPO and NYSE listing
Post date January 10, 2024 Experience Auna $550 million secured term loan refinancing We advised Auna on the transaction
Post date January 2, 2024 Experience Air Methods emerges from chapter 11 We advised the ad hoc group that negotiated and backstopped the restructuring
Post date December 21, 2023 Experience Auna exchange offer and consent solicitations We advised the Auna on the transaction
Post date December 8, 2023 Experience Option Care Health $400 million revolving credit facility We advised the administrative agent, joint lead arranger and joint bookrunner on the facility
Post date November 16, 2023 Experience Amneal Pharmaceuticals $2.35 billion term loan We advised Amneal Pharmaceuticals on a new term loan
Post date August 16, 2023 Experience Cano Health amendment and covenant waiver for side-car credit facility We advised Rubicon Founders in connection with the transaction
Post date June 30, 2023 Experience Bausch + Lomb $1.75 billion financing for acquisition of certain Novartis assets We are advising Bausch + Lomb on the financing
Post date June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Post date June 9, 2023 Experience LifeScan Global refinancing and amendment to credit facilities We advised an ad hoc group of term lenders in connection with the transaction